-
1
-
-
34249085382
-
Striatal vs. extrastriatal dopamine D2 receptors in antipsychotic response-a double-blind PET study in schizophrenia
-
Agid O, Mamo D, Ginovart N, et al. Striatal vs. extrastriatal dopamine D2 receptors in antipsychotic response-a double-blind PET study in schizophrenia. Neuropsychopharmacology. 2007 ; 32: 1209-1215
-
(2007)
Neuropsychopharmacology
, vol.32
, pp. 1209-1215
-
-
Agid, O.1
Mamo, D.2
Ginovart, N.3
-
2
-
-
77957837936
-
Positron emission tomography measurement of dopamine D2 receptor occupancy in the pituitary and cerebral cortex: Relation to antipsychotic- induced hyperprolactinemia
-
Arakawa R, Okumura M, Ito H, et al. Positron emission tomography measurement of dopamine D2 receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia. J Clin Psychiatry. 2010 ; 71: 1131-1137
-
(2010)
J Clin Psychiatry
, vol.71
, pp. 1131-1137
-
-
Arakawa, R.1
Okumura, M.2
Ito, H.3
-
3
-
-
0024358369
-
A rating scale for drug-induced akathisia
-
Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989 ; 154: 672-676
-
(1989)
Br J Psychiatry
, vol.154
, pp. 672-676
-
-
Barnes, T.R.1
-
4
-
-
0027239726
-
Dose-dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: A study using positron emission tomography and 11 C-raclopride
-
Bench CJ, Lammertsma AA, Dolan RJ, et al. Dose-dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11 C-raclopride. Psychopharmacology (Berl). 1993 ; 112: 308-314
-
(1993)
Psychopharmacology (Berl)
, vol.112
, pp. 308-314
-
-
Bench, C.J.1
Lammertsma, A.A.2
Dolan, R.J.3
-
5
-
-
0033946969
-
Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: A [123 I]epidepride single photon emission tomography (SPET) study
-
Bigliani V, Mulligan RS, Acton PD, et al. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123 I]epidepride single photon emission tomography (SPET) study. Psychopharmacology (Berl). 2000 ; 150: 132-140
-
(2000)
Psychopharmacology (Berl)
, vol.150
, pp. 132-140
-
-
Bigliani, V.1
Mulligan, R.S.2
Acton, P.D.3
-
6
-
-
12244284609
-
Optimizing limbic selective D2/D3 receptor occupancy by risperidone: A [123 I]-epidepride SPET study
-
Bressan RA, Erlandsson K, Jones HM, Mulligan RS, Ell PJ, Pilowsky LS. Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123 I]-epidepride SPET study. J Clin Psychopharmacol. 2003 ; 23: 5-14
-
(2003)
J Clin Psychopharmacol
, vol.23
, pp. 5-14
-
-
Bressan, R.A.1
Erlandsson, K.2
Jones, H.M.3
Mulligan, R.S.4
Ell, P.J.5
Pilowsky, L.S.6
-
7
-
-
9844227354
-
Performance evaluation of a whole-body PET scanner using the NEMA protocol
-
Brix G, Zaers J, Adam LE, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med. 1997 ; 38: 1614-1623
-
(1997)
J Nucl Med
, vol.38
, pp. 1614-1623
-
-
Brix, G.1
Zaers, J.2
Adam, L.E.3
-
8
-
-
0023257168
-
Synthesis of [methoxy-3H]- and [methoxy-11C]-labelled raclopride. Specific dopamine-D2 receptor ligands
-
Ehrin E, Gawell L, Hogberg T, de Paulis T, Strom P. Synthesis of [methoxy-3H]- and [methoxy-11C]-labelled raclopride. Specific dopamine-D2 receptor ligands. J Labelled Compd Radiopharm. 1987 ; 24: 931-940
-
(1987)
J Labelled Compd Radiopharm
, vol.24
, pp. 931-940
-
-
Ehrin, E.1
Gawell, L.2
Hogberg, T.3
De Paulis, T.4
Strom, P.5
-
9
-
-
0041349310
-
Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: Resolving conflicting findings
-
Erlandsson K, Bressan RA, Mulligan RS, Ell PJ, Cunningham VJ, Pilowsky LS. Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings. Neuroimage. 2003 ; 19: 1205-1214
-
(2003)
Neuroimage
, vol.19
, pp. 1205-1214
-
-
Erlandsson, K.1
Bressan, R.A.2
Mulligan, R.S.3
Ell, P.J.4
Cunningham, V.J.5
Pilowsky, L.S.6
-
10
-
-
0026718710
-
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects
-
Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry. 1992 ; 49: 538-544
-
(1992)
Arch Gen Psychiatry
, vol.49
, pp. 538-544
-
-
Farde, L.1
Nordström, A.L.2
Wiesel, F.A.3
Pauli, S.4
Halldin, C.5
Sedvall, G.6
-
11
-
-
0030609108
-
A PET study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients
-
Farde L, Suhara T, Nyberg S, et al. A PET study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology (Berl). 1997 ; 133: 396-404
-
(1997)
Psychopharmacology (Berl)
, vol.133
, pp. 396-404
-
-
Farde, L.1
Suhara, T.2
Nyberg, S.3
-
12
-
-
0023853769
-
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs
-
Farde L, Wiesel FA, Halldin C, Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry. 1988 ; 45: 71-76
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 71-76
-
-
Farde, L.1
Wiesel, F.A.2
Halldin, C.3
Sedvall, G.4
-
13
-
-
0024430178
-
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
-
Farde L, Wiesel FA, Nordström AL, Sedvall G. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology (Berl). 1989 ; 99: S28 - S31
-
(1989)
Psychopharmacology (Berl)
, vol.99
-
-
Farde, L.1
Wiesel, F.A.2
Nordström, A.L.3
Sedvall, G.4
-
14
-
-
0035055247
-
D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia: A PET study
-
Gefvert O, Lundberg T, Wieselgren IM, et al. D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia: a PET study. Eur Neuropsychopharmacol. 2001 ; 11: 105-110
-
(2001)
Eur Neuropsychopharmacol
, vol.11
, pp. 105-110
-
-
Gefvert, O.1
Lundberg, T.2
Wieselgren, I.M.3
-
15
-
-
33646137570
-
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia
-
Grunder G, Landvogt C, Vernaleken I, et al. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology. 2006 ; 31: 1027-1035
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 1027-1035
-
-
Grunder, G.1
Landvogt, C.2
Vernaleken, I.3
-
16
-
-
0031279782
-
Parametric imaging of ligand-receptor binding in PET using a simplified reference region model
-
Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997 ; 6: 279-287
-
(1997)
Neuroimage
, vol.6
, pp. 279-287
-
-
Gunn, R.N.1
Lammertsma, A.A.2
Hume, S.P.3
Cunningham, V.J.4
-
17
-
-
34547846251
-
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
-
Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007 ; 27: 1533-1539
-
(2007)
J Cereb Blood Flow Metab
, vol.27
, pp. 1533-1539
-
-
Innis, R.B.1
Cunningham, V.J.2
Delforge, J.3
-
18
-
-
69749125065
-
No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: A positron emission tomography study
-
Ito H, Arakawa R, Takahashi H, et al. No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: a positron emission tomography study. Int J Neuropsychopharmacol. 2009 ; 12: 667-675
-
(2009)
Int J Neuropsychopharmacol
, vol.12
, pp. 667-675
-
-
Ito, H.1
Arakawa, R.2
Takahashi, H.3
-
19
-
-
0034109940
-
Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action
-
Kapur S, Seeman P. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J Psychiatry Neurosci. 2000 ; 25: 161-166
-
(2000)
J Psychiatry Neurosci
, vol.25
, pp. 161-166
-
-
Kapur, S.1
Seeman, P.2
-
20
-
-
0035094264
-
Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: A new hypothesis
-
Kapur S, Seeman P. Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry. 2001 ; 158: 360-369
-
(2001)
Am J Psychiatry
, vol.158
, pp. 360-369
-
-
Kapur, S.1
Seeman, P.2
-
21
-
-
0029026941
-
The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A PET study
-
Kapur S, Remington G, Zipursky RB, Wilson AA, Houle S. The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. Life Sci. 1995 ; 57: L103 - L107
-
(1995)
Life Sci
, vol.57
-
-
Kapur, S.1
Remington, G.2
Zipursky, R.B.3
Wilson, A.A.4
Houle, S.5
-
22
-
-
0034025771
-
Relationship between dopamine D2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia
-
Kapur S, Zipursky R, Jones C, Remington G, Houle S. Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry. 2000a ; 157: 514-520
-
(2000)
Am J Psychiatry
, vol.157
, pp. 514-520
-
-
Kapur, S.1
Zipursky, R.2
Jones, C.3
Remington, G.4
Houle, S.5
-
23
-
-
0030300171
-
The D2 receptor occupancy profile of loxapine determined using PET
-
Kapur S, Zipursky RB, Jones C, et al. The D2 receptor occupancy profile of loxapine determined using PET. Neuropsychopharmacology. 1996 ; 15: 562-566
-
(1996)
Neuropsychopharmacology
, vol.15
, pp. 562-566
-
-
Kapur, S.1
Zipursky, R.B.2
Jones, C.3
-
24
-
-
0034091239
-
A positron emission tomography study of quetiapine in schizophrenia: A preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy
-
Kapur S, Zipursky R, Jones C, Shammi CS, Remington G, Seeman P. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry. 2000b ; 57: 553-559
-
(2000)
Arch Gen Psychiatry
, vol.57
, pp. 553-559
-
-
Kapur, S.1
Zipursky, R.2
Jones, C.3
Shammi, C.S.4
Remington, G.5
Seeman, P.6
-
25
-
-
0031595586
-
5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation
-
Kapur S, Zipursky RB, Remington G, et al. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry. 1998 ; 155: 921-928
-
(1998)
Am J Psychiatry
, vol.155
, pp. 921-928
-
-
Kapur, S.1
Zipursky, R.B.2
Remington, G.3
-
26
-
-
0032982714
-
Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
-
Kapur S, Zipursky RB, Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry. 1999 ; 156: 286-293
-
(1999)
Am J Psychiatry
, vol.156
, pp. 286-293
-
-
Kapur, S.1
Zipursky, R.B.2
Remington, G.3
-
27
-
-
0030613524
-
The relationship between D2 receptor occupancy and plasma levels on low-dose oral haloperidol: A PET study
-
Kapur S, Zipursky R, Roy P, et al. The relationship between D2 receptor occupancy and plasma levels on low-dose oral haloperidol: a PET study. Psychopharmacology (Berl). 1997 ; 131: 148-152
-
(1997)
Psychopharmacology (Berl)
, vol.131
, pp. 148-152
-
-
Kapur, S.1
Zipursky, R.2
Roy, P.3
-
28
-
-
57349125689
-
Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride
-
Kegeles LS, Slifstein M, Frankle WG, et al. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Neuropsychopharmacology. 2008 ; 33: 3111-3125
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 3111-3125
-
-
Kegeles, L.S.1
Slifstein, M.2
Frankle, W.G.3
-
29
-
-
0036272770
-
Regional selectivity in clozapine treatment?
-
Kessler RM, Meltzer HY. Regional selectivity in clozapine treatment?. Am J Psychiatry. 2002 ; 159: 1064-1065
-
(2002)
Am J Psychiatry
, vol.159
, pp. 1064-1065
-
-
Kessler, R.M.1
Meltzer, H.Y.2
-
30
-
-
27844538830
-
Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol
-
Kessler RM, Ansari MS, Riccardi P, et al. Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol. Neuropsychopharmacology. 2005 ; 30: 2283-2289
-
(2005)
Neuropsychopharmacology
, vol.30
, pp. 2283-2289
-
-
Kessler, R.M.1
Ansari, M.S.2
Riccardi, P.3
-
31
-
-
33747353835
-
Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine
-
Kessler RM, Ansari MS, Riccardi P, et al. Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine. Neuropsychopharmacology. 2006 ; 31: 1991-2001
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 1991-2001
-
-
Kessler, R.M.1
Ansari, M.S.2
Riccardi, P.3
-
32
-
-
50349086333
-
Neuropharmacology of second-generation antipsychotic drugs: A validity of the serotonin-dopamine hypothesis
-
Kuroki T, Nagao N, Nakahara T. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Prog Brain Res. 2008 ; 172: 199-212
-
(2008)
Prog Brain Res
, vol.172
, pp. 199-212
-
-
Kuroki, T.1
Nagao, N.2
Nakahara, T.3
-
33
-
-
0030468875
-
Simplified reference tissue model for PET receptor studies
-
Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996 ; 4: 153-158
-
(1996)
Neuroimage
, vol.4
, pp. 153-158
-
-
Lammertsma, A.A.1
Hume, S.P.2
-
34
-
-
84862877299
-
Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia
-
Langlois X, Megens A, Lavreysen H, et al. Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia. Eur Neuropsychopharmacol. 2010 ; 20: S502
-
(2010)
Eur Neuropsychopharmacol
, vol.20
, pp. 502
-
-
Langlois, X.1
Megens, A.2
Lavreysen, H.3
-
35
-
-
34648830603
-
Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia: A triple tracer PET study
-
Mamo D, Graff A, Mizrahi R, Shammi CM, Romeyer F, Kapur S. Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry. 2007 ; 164: 1411-1417
-
(2007)
Am J Psychiatry
, vol.164
, pp. 1411-1417
-
-
Mamo, D.1
Graff, A.2
Mizrahi, R.3
Shammi, C.M.4
Romeyer, F.5
Kapur, S.6
-
36
-
-
2442457725
-
A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone
-
Mamo D, Kapur S, Shammi CM, et al. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone. Am J Psychiatry. 2004 ; 161: 818-825
-
(2004)
Am J Psychiatry
, vol.161
, pp. 818-825
-
-
Mamo, D.1
Kapur, S.2
Shammi, C.M.3
-
37
-
-
0036357466
-
Action of atypical antipsychotics
-
Meltzer HY. Action of atypical antipsychotics. Am J Psychiatry. 2002 ; 159: 153-154
-
(2002)
Am J Psychiatry
, vol.159
, pp. 153-154
-
-
Meltzer, H.Y.1
-
39
-
-
12344326514
-
Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs
-
Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005 ; 10: 79-104
-
(2005)
Mol Psychiatry
, vol.10
, pp. 79-104
-
-
Miyamoto, S.1
Duncan, G.E.2
Marx, C.E.3
Lieberman, J.A.4
-
40
-
-
0026612906
-
Time course of D2- dopamine receptor occupancy examined by PET after single oral doses of haloperidol
-
Nordström AL, Farde L, Halldin C. Time course of D2- dopamine receptor occupancy examined by PET after single oral doses of haloperidol. Psychopharmacology (Berl). 1992 ; 106: 433-438
-
(1992)
Psychopharmacology (Berl)
, vol.106
, pp. 433-438
-
-
Nordström, A.L.1
Farde, L.2
Halldin, C.3
-
41
-
-
0033014402
-
Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients
-
Nyberg S, Eriksson B, Oxenstierna G, Halldin C, Farde L. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. Am J Psychiatry. 1999 ; 156: 869-875
-
(1999)
Am J Psychiatry
, vol.156
, pp. 869-875
-
-
Nyberg, S.1
Eriksson, B.2
Oxenstierna, G.3
Halldin, C.4
Farde, L.5
-
42
-
-
0027341623
-
5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone
-
Nyberg S, Farde L, Eriksson L, Halldin C, Eriksson B. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacology (Berl). 1993 ; 110: 265-272
-
(1993)
Psychopharmacology (Berl)
, vol.110
, pp. 265-272
-
-
Nyberg, S.1
Farde, L.2
Eriksson, L.3
Halldin, C.4
Eriksson, B.5
-
43
-
-
0028982509
-
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate
-
Nyberg S, Farde L, Halldin C, Dahl ML, Bertilsson L. D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. Am J Psychiatry. 1995a ; 152: 173-178
-
(1995)
Am J Psychiatry
, vol.152
, pp. 173-178
-
-
Nyberg, S.1
Farde, L.2
Halldin, C.3
Dahl, M.L.4
Bertilsson, L.5
-
44
-
-
0031014718
-
A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects
-
Nyberg S, Farde L, Halldin C. A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects. Neuropsychopharmacology. 1997 ; 16: 1-7
-
(1997)
Neuropsychopharmacology
, vol.16
, pp. 1-7
-
-
Nyberg, S.1
Farde, L.2
Halldin, C.3
-
45
-
-
0029583353
-
Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man
-
Nyberg S, Nordström AL, Halldin C, Farde L. Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man. Int Clin Psychopharmacol. 1995b ; 10: 81-85
-
(1995)
Int Clin Psychopharmacol
, vol.10
, pp. 81-85
-
-
Nyberg, S.1
Nordström, A.L.2
Halldin, C.3
Farde, L.4
-
46
-
-
0034805368
-
Potentials and pitfalls using high-affinity radioligands in PET and SPET determinations on regional drug-induced D2 receptor occupancy-a simulation study based on experimental data
-
Olsson H, Farde L. Potentials and pitfalls using high-affinity radioligands in PET and SPET determinations on regional drug-induced D2 receptor occupancy-a simulation study based on experimental data. Neuroimage. 2001 ; 14: 936-945
-
(2001)
Neuroimage
, vol.14
, pp. 936-945
-
-
Olsson, H.1
Farde, L.2
-
47
-
-
34547110810
-
Antipsychotic efficacy: Relationship to optimal D2-receptor occupancy
-
Pani L, Pira L, Marchese G. Antipsychotic efficacy: relationship to optimal D2-receptor occupancy.. Eur Psychiatry. 2007 ; 22: 267-275
-
(2007)
Eur Psychiatry
, vol.22
, pp. 267-275
-
-
Pani, L.1
Pira, L.2
Marchese, G.3
-
48
-
-
0030859144
-
Limbic selectivity of clozapine
-
Pilowsky LS, Mulligan RS, Acton PD, Ell PJ, Costa DC, Kerwin RW. Limbic selectivity of clozapine. Lancet. 1997 ; 350: 490-491
-
(1997)
Lancet
, vol.350
, pp. 490-491
-
-
Pilowsky, L.S.1
Mulligan, R.S.2
Acton, P.D.3
Ell, P.J.4
Costa, D.C.5
Kerwin, R.W.6
-
49
-
-
0031973814
-
The relationship between risperidone plasma levels and dopamine D2 occupancy: A positron emission tomographic study
-
Remington G, Kapur S, Zipursky R. The relationship between risperidone plasma levels and dopamine D2 occupancy: a positron emission tomographic study. J Clin Psychopharmacol. 1998 ; 18: 82-83
-
(1998)
J Clin Psychopharmacol
, vol.18
, pp. 82-83
-
-
Remington, G.1
Kapur, S.2
Zipursky, R.3
-
50
-
-
0042029747
-
Atypical antipsychotic drug actions: Unitary or multiple mechanisms for 'atypicality'?
-
Roth BL, Sheffler D, Potkin SG. Atypical antipsychotic drug actions: unitary or multiple mechanisms for 'atypicality'?. Clin Neurosci Res. 2003 ; 3: 108-117
-
(2003)
Clin Neurosci Res
, vol.3
, pp. 108-117
-
-
Roth, B.L.1
Sheffler, D.2
Potkin, S.G.3
-
51
-
-
84864139978
-
Safety, tolerability and D2 occupancy of the fast-dissociating D2 antagonist JNJ-37822681 in healthy subjects
-
Schmidt M, De Boer P, Mannaert E, Iersel T, Van Nueten L. Safety, tolerability and D2 occupancy of the fast-dissociating D2 antagonist JNJ-37822681 in healthy subjects. Eur Neuropsychopharmacol. 2010a ; 20: S444
-
(2010)
Eur Neuropsychopharmacol
, vol.20
, pp. 444
-
-
Schmidt, M.1
De Boer, P.2
Mannaert, E.3
Iersel, T.4
Van Nueten, L.5
-
52
-
-
84862883746
-
Efficacy and safety of JNJ-37822681, a fast-dissociating D2 receptor antagonist, in the treatment of schizophrenia
-
Schmidt M, Janssens L, Kent J, et al. Efficacy and safety of JNJ-37822681, a fast-dissociating D2 receptor antagonist, in the treatment of schizophrenia. Eur Neuropsychopharmacol. 2010b ; 20: S484 - S485
-
(2010)
Eur Neuropsychopharmacol
, vol.20
-
-
Schmidt, M.1
Janssens, L.2
Kent, J.3
-
53
-
-
84864130375
-
D2 receptor occupancy with 11C-raclopride PET following single and multiple dose: Does steady state make a difference?
-
Schmidt M, Mannaert E, De Boer P, et al. D2 receptor occupancy with 11C-raclopride PET following single and multiple dose: does steady state make a difference?. Eur Neuropsychopharmacol. 2009 ; 19: S314
-
(2009)
Eur Neuropsychopharmacol
, vol.19
, pp. 314
-
-
Schmidt, M.1
Mannaert, E.2
De Boer, P.3
-
54
-
-
0036221550
-
Atypical antipsychotics: Mechanism of action
-
Seeman P. Atypical antipsychotics: Mechanism of action. Can J Psychiatry. 2002 ; 47: 27-38
-
(2002)
Can J Psychiatry
, vol.47
, pp. 27-38
-
-
Seeman, P.1
-
55
-
-
26444441486
-
An update of fast-off dopamine D2 atypical antipsychotics
-
Seeman P. An update of fast-off dopamine D2 atypical antipsychotics. Am J Psychiatry. 2005 ; 162: 1984-1985
-
(2005)
Am J Psychiatry
, vol.162
, pp. 1984-1985
-
-
Seeman, P.1
-
56
-
-
0031953450
-
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors
-
Seeman P, Tallerico T. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry. 1998 ; 3: 123-134
-
(1998)
Mol Psychiatry
, vol.3
, pp. 123-134
-
-
Seeman, P.1
Tallerico, T.2
-
57
-
-
0032973806
-
Rapid release of antipsychotic drugs from dopamine D2 receptors: An explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine
-
Seeman P, Tallerico T. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am J Psychiatry. 1999 ; 156: 876-884
-
(1999)
Am J Psychiatry
, vol.156
, pp. 876-884
-
-
Seeman, P.1
Tallerico, T.2
-
59
-
-
24944441752
-
Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride
-
Stone JM, Bressan RA, Erlandsson K, Ell PJ, Pilowsky LS. Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride. Psychopharmacology (Berl). 2005 ; 180: 664-669
-
(2005)
Psychopharmacology (Berl)
, vol.180
, pp. 664-669
-
-
Stone, J.M.1
Bressan, R.A.2
Erlandsson, K.3
Ell, P.J.4
Pilowsky, L.S.5
-
60
-
-
68149148941
-
Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs-an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature
-
Stone JM, Davis JM, Leucht S, Pilowsky LS. Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs-an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature. Schizophr Bull. 2009 ; 35: 789-797
-
(2009)
Schizophr Bull
, vol.35
, pp. 789-797
-
-
Stone, J.M.1
Davis, J.M.2
Leucht, S.3
Pilowsky, L.S.4
-
61
-
-
12844261790
-
MR-based automatic delineation of volumes of interest in human brain PET images using probability maps
-
Svarer C, Madsen K, Hasselbalch SG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage. 2005 ; 24: 969-979
-
(2005)
Neuroimage
, vol.24
, pp. 969-979
-
-
Svarer, C.1
Madsen, K.2
Hasselbalch, S.G.3
-
62
-
-
0034974721
-
No support for regional selectivity in clozapine-treated patients: A PET study with [11C]raclopride and [11C]FLB 457
-
Talvik M, Nordstrom AL, Nyberg S, Olsson H, Halldin C, Farde L. No support for regional selectivity in clozapine-treated patients: A PET study with [11C]raclopride and [11C]FLB 457. Am J Psychiatry. 2001 ; 158: 926-930
-
(2001)
Am J Psychiatry
, vol.158
, pp. 926-930
-
-
Talvik, M.1
Nordstrom, A.L.2
Nyberg, S.3
Olsson, H.4
Halldin, C.5
Farde, L.6
-
63
-
-
0036855229
-
Quetiapine: An effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade
-
Tauscher-Wisniewski S, Kapur S, Tauscher J, et al. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade. J Clin Psychiatry. 2002 ; 63: 992-997
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 992-997
-
-
Tauscher-Wisniewski, S.1
Kapur, S.2
Tauscher, J.3
-
64
-
-
84864137154
-
Pharmacokinetics and central nervous system effects of the novel dopamine D2 receptor antagonist JNJ-37822681
-
Te Beek ET, Moerland M, De Boer P, et al. Pharmacokinetics and central nervous system effects of the novel dopamine D2 receptor antagonist JNJ-37822681. J Psychopharmacol. 2012 ; 26: 1119-1127
-
(2012)
J Psychopharmacol
, vol.26
, pp. 1119-1127
-
-
Te Beek, E.T.1
Moerland, M.2
De Boer, P.3
-
65
-
-
49649110740
-
Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia
-
Uchida H, Mamo DC, Kapur S, et al. Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia. J Clin Psychiatry. 2008 ; 69: 1281-1286
-
(2008)
J Clin Psychiatry
, vol.69
, pp. 1281-1286
-
-
Uchida, H.1
Mamo, D.C.2
Kapur, S.3
-
66
-
-
59049100213
-
Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: A positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone)
-
Vernaleken I, Fellows C, Janouschek H, et al. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone). J Clin Psychopharmacol. 2008 ; 28: 608-617
-
(2008)
J Clin Psychopharmacol
, vol.28
, pp. 608-617
-
-
Vernaleken, I.1
Fellows, C.2
Janouschek, H.3
-
67
-
-
77957234962
-
Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas
-
Vernaleken I, Janouschek H, Raptis M, et al. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas. Int J Neuropsychopharmacol. 2010 ; 13: 951-960
-
(2010)
Int J Neuropsychopharmacol
, vol.13
, pp. 951-960
-
-
Vernaleken, I.1
Janouschek, H.2
Raptis, M.3
-
68
-
-
0035675612
-
Extrastriatal and striatal D2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia
-
Xiberas X, Martinot JL, Mallet L, et al. Extrastriatal and striatal D2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. Br J Psychiatry. 2001 ; 179: 503-508
-
(2001)
Br J Psychiatry
, vol.179
, pp. 503-508
-
-
Xiberas, X.1
Martinot, J.L.2
Mallet, L.3
-
69
-
-
0035983682
-
Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): A study using positron emission tomography and [11C]raclopride
-
Yokoi F, Grunder G, Biziere K, et al. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Neuropsychopharmacology. 2002 ; 27: 248-259
-
(2002)
Neuropsychopharmacology
, vol.27
, pp. 248-259
-
-
Yokoi, F.1
Grunder, G.2
Biziere, K.3
-
70
-
-
25444493183
-
Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis
-
Zipursky RB, Christensen BK, Daskalakis Z, et al. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis. Can J Psychiatry. 2005 ; 50: 462-469
-
(2005)
Can J Psychiatry
, vol.50
, pp. 462-469
-
-
Zipursky, R.B.1
Christensen, B.K.2
Daskalakis, Z.3
|